Cholangiocarcinoma
Conditions
Interventions
Traditional Chinese medicine + chemotherapy group:Spleen and tumor decoction + gemcitabine + cisplatin/oxaliplatin
Chemotherapy group:Gemcitabine + cisplatin/oxaliplatin
Sponsors
HENAN PROVINCE HOSPITAL OF TCM
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) Age> 18 years old, gender is not limited; (2) Patients with a clear pathological diagnosis and clinical stage II-I; (3) No anti-tumor therapy and agreement to treatment within 2 weeks prior to enrollment; (4) KPS score >60 points: (5) The estimated survival time is greater than 3 months; (6) Patients without serious heart, lung, liver, kidney, brain and other organ diseases; (7) Obtain informed consent signed by the subject or his/her legal representative; (8) Those who can cooperate with the completion of research procedures and follow-up examinations.
Exclusion criteria
Exclusion criteria: (1) Currently receiving chemoradiotherapy, targeted therapy, etc.; (2) Investigators who are participating in other clinical trials; (3) Those with serious diseases of the heart, brain, lungs, liver, kidneys and hematopoietic system; (4) Factors affecting the efficacy such as failure to use drugs as prescribed, inability to determine the efficacy or incomplete data; (5) Those with allergies or allergies to the test drug; (6) Pregnant or lactating women and patients with mental illness; (7) Those who cannot cooperate with the completion of this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Immunological Indicators;therapeutic efficacy indicators; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM Symptom Score;transcriptome analysis;Quality of Life Score; | — |
Countries
China
Contacts
Public ContactZhizhongGuo
HENAN PROVINCE HOSPITAL OF TCM
Outcome results
None listed